[ Price : $8.95]
Lawmakers introduce a bill to ensure access to over-the-counter oral birth control drugs.[ Price : $8.95]
Global Forum representatives from 12 major drug companies call for a Covid-19-like approach to therapies for other significant dis...[ Price : $8.95]
The Association for Accessible Medicines says it is concerned that FDA does not have statutory authority for its proposed quality ...[ Price : $8.95]
Sens. Marshall and Braun propose legislation to limit how FDA communicates medical device safety information.[ Price : $8.95]
FDA approves Sanofis Dupixent (dupilumab) for children aged six months to five years with moderate-to-severe atopic dermatitis who...[ Price : $8.95]
Outlook Therapeutics says it has withdrawn a BLA submitted in March for Lytenava (bevacizumab-vikg) for treating wet age-related m...[ Price : $8.95]
FDA posts information on accreditation body participation in the Accreditation Scheme for Conformity Assessment pilot program.[ Price : $8.95]
FDA grants Allogene Therapeutics a regenerative medicine advanced therapy designation for ALLO-501A in relapsed/refractory large B...